Uptake of human papiloma virus vaccine among women aged 18-45 yrs in Umoja area of Embakasi sub-county of Nairobi county, Kenya
Loading...
Date
2014-11-03
Authors
Mibuku, Fredrick Kairithia
Journal Title
Journal ISSN
Volume Title
Publisher
Kenyatta University
Abstract
Cervical cancer kills 270,060 women annually worldwide. III Kenya up to 1655 women die
annually. Cervical cancer screening and the uptake of Human Papilloma Virus (HPV) vaccine
can result in early detection whereas HPV vaccination can lead to prevention of infection with
cancer causing strains among women. Pre-pubertal girls are being targeted for vaccination before
their sexual debut although preventive benefits have been documented in older women. Thus,
there have been efforts at the local, national and global level to promote cancer screening and to
provide information on HPV and promote its uptake in Kenya. Despite these efforts, only 6% of
women in Kenya have ever been screened for Pap smear while less than •1% has had HPV
vaccine. There are many determinants to the uptake of pap HPV vaccine. Previous studies have
identified cost of the vaccine, inaccessibility, lack of awareness, reservations by clinicians as
main hindrances to the uptake of the vaccine. This study seeks to determine the factors that
influence the uptake of HPV vaccine among women of reproductive age in Umoja Division,
Nairobi. Specifically, the study will assess the level of uptake ofHPV among women in selected
sites. It will also investigate the experiences of women that have led to their uptake .or nonuptake
of the vaccine. Further, the study will identify barriers to uptake of HPV vaccine by
women aged 18-45yrs at Embakasi district of Nairobi county, Kenya. The study will use a cross
sectional descriptive design. A total of 384 women will be sampled randomly and interviewed to
determine if they have had HPV vaccine. Data will be collected using an interview schedule
containing closed and. open-ended questions. Data analysis will be done using SPSS computer
program